Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage III Malignant Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05370807
What this trial is testing

A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Universitair Ziekenhuis Brussel 48
Testing effectiveness (Phase 2)WithdrawnNCT01764009
What this trial is testing

Safety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Metastatic Melanoma

Who this might be right for
Melanoma
Valerio Therapeutics
Not applicableStudy completedNCT01986712
What this trial is testing

Compare Quality of Life and Compliance in Patients Receiving High-dose Interferon Versus Pegylated Interferon in Patients With Surgically Resected Melanoma

Who this might be right for
Melanoma
St. Luke's Hospital and Health Network, Pennsylvania 50
Large-scale testing (Phase 3)Active Not RecruitingNCT02938299
What this trial is testing

Neoadjuvant L19IL2/L19TNF- Pivotal Study

Who this might be right for
Malignant Melanoma
Philogen S.p.A. 214
Testing effectiveness (Phase 2)Study completedNCT00089219
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma

Who this might be right for
Intraocular MelanomaMelanoma (Skin)
University of Virginia 39
Testing effectiveness (Phase 2)Looking for participantsNCT05655312
What this trial is testing

MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma

Who this might be right for
Recurrent Melanoma (Skin)Metastatic MelanomaMelanoma Stage IV+1 more
Perspective Therapeutics 300
Early research (Phase 1)Ended earlyNCT00667901
What this trial is testing

Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery

Who this might be right for
Melanoma (Skin)
University of Medicine and Dentistry of New Jersey 15
Testing effectiveness (Phase 2)WithdrawnNCT02452281
What this trial is testing

Pilot Study to Evaluate the Effects of a Vaccine (HSPPC-96) Combined With Ipilimumab in Patients With Advanced Melanoma

Who this might be right for
Melanoma
Rabih Said
Not applicableNo Longer AvailableNCT04544202
What this trial is testing

Compassionate Use Program BRAF Mutation-positive Patients in the Adjuvant Treatment of Melanoma After Surgical Resection

Who this might be right for
MelanomaAdjuvant
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT00101166
What this trial is testing

Universal Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)-Producing and CD40L Expressing Bystander Cell Line for Tumor Vaccine in Melanoma

Who this might be right for
Melanoma (Skin)
H. Lee Moffitt Cancer Center and Research Institute 43
Large-scale testing (Phase 3)Study completedNCT02599402
What this trial is testing

Nivolumab Combined With Ipilimumab Followed by Nivolumab Monotherapy as First-Line Treatment for Patients With Advanced Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 533
Not applicableLooking for participantsNCT06754904
What this trial is testing

Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node

Who this might be right for
Melanoma, Skin
D.J. (Dirk) Grünhagen 213
Early research (Phase 1)Ended earlyNCT04990479
What this trial is testing

Nous-PEV: a Novel Immunotherapy for Lung Cancer and Melanoma

Who this might be right for
Melanoma (Skin)Non-Small-Cell Lung Carcinoma
Nouscom SRL 7
Testing effectiveness (Phase 2)WithdrawnNCT04007588
What this trial is testing

A Phase II Trial of Neoadjuvant Treatment With PD-1 Inhibition (Nivolumab) With or Without IDO Inhibition (BMS-986205) and With or Without CTLA-4 Inhibition (Ipilimumab) in Resectable Stage III or IV Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Dana-Farber Cancer Institute
Large-scale testing (Phase 3)Ended earlyNCT02288897
What this trial is testing

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

Who this might be right for
Cutaneous Melanoma
Provectus Biopharmaceuticals, Inc. 20
Not applicableActive Not RecruitingNCT05736523
What this trial is testing

Improving Early Detection of Melanoma Recurrence With Circulating Tumor DNA (ctDNA)

Who this might be right for
Melanoma
University of Utah 28
Early research (Phase 1)Study completedNCT00790010
What this trial is testing

Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma

Who this might be right for
Melanoma
Dana-Farber Cancer Institute 46
Large-scale testing (Phase 3)WithdrawnNCT01861938
What this trial is testing

Modified Melanoma Vaccine for High Risk or Low Residual Disease Patients

Who this might be right for
High Risk HLA-A2+ MelanomaMetastatic Disease
Hadassah Medical Organization
Not applicableStudy completedNCT01886235
What this trial is testing

Intravital Microscopy for Identifying Tumor Vessels in Patients With Stage IA-IV Melanoma That is Being Removed by Surgery

Who this might be right for
Recurrent MelanomaStage IA Skin MelanomaStage IB Skin Melanoma+7 more
Roswell Park Cancer Institute 10
Testing effectiveness (Phase 2)Study completedNCT02272855
What this trial is testing

Combination Treatment With HF10 and Ipilimumab in Patients With Unresectable or Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Takara Bio Inc. 46
Next Page